Young anti-aging field takes big step with Mayo Clinic senolytics showcase
The idea that flushing senescent cells — those old, fatigued cells that cease to divide — from the body may rid the body of harmful proteins has been one of the prominent proposals in the anti-aging sphere. Having generated a stream of animal data to support the hypothesis, the Mayo Clinic now has results from an early human study suggesting they have found drugs that can do exactly that.
To be sure, the main goal of the Phase I trial wasn’t to show the effects of decreasing senescent cells in the body; rather, the scientists were keen to prove that a senolytic regimen they’ve tested in mice works the same way in humans.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.